Endometrial cancer diagnosed by pelvic MRI is generally more accurate, but diagnosis still needs to be confirmed by diagnostic curettage and hysteroscopy. In addition, pelvic MRI can determine the degree of infiltration of endometrial cancer, so this test is more important. Endometrial cancer, also known as uterine body cancer, is an epithelial malignant tumor occurring in the endometrium, which is mostly seen in perimenopausal and postmenopausal women. Endometrial cancer needs to be further diagnosed through ultrasound, CT, MRI, tumor marker, diagnostic curettage and hysteroscopy. Endometrial cancer can often be diagnosed by diagnostic curettage, a histopathologic examination of the endometrium. Nowadays, hysteroscopy can also be used to observe the presence of cancerous foci in the uterine cavity and cervical canal, and biopsy of suspicious lesions can also be performed to detect smaller early lesions. Pelvic MRI is the imaging examination of choice for endometrial cancer, which can clearly show the endometrial and muscular structure of the uterus, clarify the size and location of the lesion, and also observe whether the lesion invades the cervix, vagina, bladder, rectum and other parts of the uterus, as well as the metastasis of the tumor in the pelvic cavity, retroperitoneal area and lymph nodes in the inguinal area. If symptoms related to endometrial cancer such as vaginal bleeding and abnormal vaginal discharge occur, please follow the doctor’s instruction to improve the relevant examination and treatment.